Invention Grant
- Patent Title: Human anti-IFN-α antibodies
-
Application No.: US17154350Application Date: 2021-01-21
-
Publication No.: US11945861B2Publication Date: 2024-04-02
- Inventor: Syeda F. Y. Haque , Adrian Hayday , Kai Kisand , Kai Krohn , Annalisa Macagno , Steffen Meyer , Paert Peterson , Mike Rothe , Philip Vlaicu , Martin Woodward
- Applicant: IMMUNOQURE AG
- Applicant Address: DE Dusseldorf
- Assignee: IMMUNOQURE AG
- Current Assignee: IMMUNOQURE AG
- Current Assignee Address: DE Dusseldorf
- Agency: Sheridan Ross P.C.
- Priority: EP 174995 2013.07.03
- The original application number of the division: US16133352 2018.09.17
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K47/68 ; G01N33/564 ; G01N33/68
Abstract:
Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-α antibodies as well as IFN-α binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.
Public/Granted literature
- US20210221883A1 HUMAN ANTI-IFN-ALPHA ANTIBODIES Public/Granted day:2021-07-22
Information query
